Today's Date
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
(
ACCESS
)
ITN Protocol #:
ITN034AI
Branded Name:
ACCESS
ClinicalTrials.Gov ID:
NCT00774852Treatment Protocol #:
Abatacept
Therapeutic Area:
Autoimmune Disease
Current Status:
Complete
Summary:
A Randomized, Double-blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
Clinical Operations Manager
ITN Biologist
ITN Biostat
ITN Clinical Trial Physician
NIAID Project Manager
Rho Data Manager
Rho Scientist
PPD Lead Monitor
Study Personnel:
